ES2174388T3 - Solucion liquida de medicamento para administracion oral. - Google Patents

Solucion liquida de medicamento para administracion oral.

Info

Publication number
ES2174388T3
ES2174388T3 ES98202077T ES98202077T ES2174388T3 ES 2174388 T3 ES2174388 T3 ES 2174388T3 ES 98202077 T ES98202077 T ES 98202077T ES 98202077 T ES98202077 T ES 98202077T ES 2174388 T3 ES2174388 T3 ES 2174388T3
Authority
ES
Spain
Prior art keywords
oral administration
medicinal solution
liquid medicinal
volume
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98202077T
Other languages
English (en)
Inventor
Roger Edward Tully
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2174388T3 publication Critical patent/ES2174388T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE HA ENCONTRADO UNA PREPARACION FARMACEUTICA QUE PROPORCIONA CITRATO DE TAMOXIFENO EN FORMA LIQUIDA, ES DECIR, COMO SOLUCION PARA LA VIA ORAL. EL HALLAZGO SE BASA EN UN DISOLVENTE QUE COMPRENDE LOS COMPONENTES SIGUIENTES: (A) DE UN 10 A UN 20% EN PESO DE ETANOL; (B) DE UN 10 A UN 60% EN PESO DE UN GLICOL; Y (C) AGUA, CONTENIENDO OPTATIVAMENTE ADITIVOS, EN UN PORCENTAJE EN VOLUMEN QUE REPRESENTA UN TOTAL DEL 100% EN VOLUMEN. UN ADITIVO PREFERIDO ES EL SORBITOL.
ES98202077T 1997-06-27 1998-06-23 Solucion liquida de medicamento para administracion oral. Expired - Lifetime ES2174388T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201964 1997-06-27

Publications (1)

Publication Number Publication Date
ES2174388T3 true ES2174388T3 (es) 2002-11-01

Family

ID=8228492

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98202077T Expired - Lifetime ES2174388T3 (es) 1997-06-27 1998-06-23 Solucion liquida de medicamento para administracion oral.

Country Status (8)

Country Link
US (1) US6127425A (es)
EP (1) EP0893121B1 (es)
JP (1) JPH1171269A (es)
AT (1) ATE214269T1 (es)
DE (1) DE69804169T2 (es)
DK (1) DK0893121T3 (es)
ES (1) ES2174388T3 (es)
PT (1) PT893121E (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
FI982733L (fi) 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
US6541367B1 (en) * 2000-01-18 2003-04-01 Applied Materials, Inc. Very low dielectric constant plasma-enhanced CVD films
FR2910317B1 (fr) * 2006-12-21 2009-02-13 Philippe Perovitch Forme galenique pour l'administration par voie transmuqueuse de paracetamol
KR101025498B1 (ko) * 2008-05-02 2011-03-31 (주)이엘티사이언스 염산브롬헥신 경구용 액제 복합조성물 및 그 제조방법
WO2012142029A2 (en) 2011-04-10 2012-10-18 Florida A&M University Serms for the treatment of estrogen receptor-mediated disorders
ITUA20162292A1 (it) * 2016-04-05 2017-10-05 Gb Pharma S R L Uso del tamoxifene per il trattamento della fibrosi cistica in pazienti di entrambi i sessi

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE293263C (es) *
WO1984001506A1 (en) * 1982-10-13 1984-04-26 Univ Birmingham Pharmaceutical preparations for use in antitumour therapy
GB8604528D0 (en) * 1986-02-24 1986-04-03 Ici Plc Therapeutic agents
DD293263A5 (de) * 1990-03-23 1991-08-29 Adw,Zi Fuer Molekularbiologie,De Mittel zur hemmung des tumorwachstums
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
IT1263831B (it) * 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
DE4335876A1 (de) * 1993-10-17 1995-04-20 Schering Ag Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
TW389694B (en) * 1995-08-17 2000-05-11 Novartis Ag Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics

Also Published As

Publication number Publication date
EP0893121B1 (en) 2002-03-13
JPH1171269A (ja) 1999-03-16
US6127425A (en) 2000-10-03
DE69804169T2 (de) 2002-08-29
EP0893121A1 (en) 1999-01-27
PT893121E (pt) 2002-06-28
DE69804169D1 (de) 2002-04-18
DK0893121T3 (da) 2002-06-17
ATE214269T1 (de) 2002-03-15

Similar Documents

Publication Publication Date Title
ES8608875A1 (es) Un metodo para preparar una composicion farmaceutica para aplicacion topica que contiene 1-dodecilazacicloheptan-2-ona.
ES2079210T3 (es) Formulacion farmaceutica de aerosol.
AR033221A1 (es) Composicion farmaceutica finamente autoemulsionable
ES2162927T3 (es) Formulacion para la aplicacion por inhalacion.
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
SE8700498L (sv) Nya farmakologiskt aktiva foreningar
SV2002000969A (es) Composicion parenteral reconstituible
ES2031904T3 (es) Procedimiento para producir una composicion farmaceutica que contiene ibuprofeno y hidroxido de aluminio.
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
KR890016966A (ko) 신규 항바이러스제
ES2080844T3 (es) Composiciones administradas topicamente basadas en acido hialuronico de alto peso molecular para el tratamiento de las inflamaciones de la cavidad oral y para la higiene y el tratamiento cosmetico de la cavidad oral.
ES2174388T3 (es) Solucion liquida de medicamento para administracion oral.
AR019053A1 (es) Uso de 2'2'-difluoronucleosidos para la preparacion de un medicamento y composicion farmaceutica y producto farmaceutico que los contienen
ES2091977T3 (es) Formulacion de acetato de megestrol.
ES2192256T3 (es) Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas.
ES2029254T3 (es) Procedimiento para la preparacion de una sal de diclofenac con una base organica ciclica.
ES2171525T3 (es) Composiciones farmaceuticas para uso topico conteniendo acido (s)-2-(4-isobutilfenil)propionico.
CO5560585A2 (es) Formulacion farmaceutica para administracion intramuscular de fulvestrant
FR2363330A1 (fr) Medicament destine a reduire la fertilite chez les mammiferes
ES2091183T3 (es) Metodo para mejorar el sueño.
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
ES2078838A1 (es) Procedimiento para preparar una composicion a base de clozapina.
ES2059130T3 (es) Composiciones farmaceuticas que contienen ipriflavona, procedimiento para su preparacion y uso terapeutico relacionado.
ES2197781B1 (es) Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
PE20001108A1 (es) Concentrado oral de sertralina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 893121

Country of ref document: ES